SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

Lion Point Capital, LP's Holding History (CIK: 0001643354)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 36,000 Value ($000) $756 Avg Close $17.45 Range $12.99 - $22.73
Q3 2025
Shares 55,000 Value ($000) $846 Avg Close $13.09 Range $8.59 - $17.24
Q2 2025
Shares 55,000 Value ($000) $515 Avg Close $11.01 Range $8.58 - $14.24
Q1 2025
Shares 55,000 Value ($000) $676 Avg Close $14.10 Range $12.06 - $16.95
Q4 2024
Shares 55,000 Value ($000) $727 Avg Close $17.11 Range $12.40 - $22.50
Q3 2024
Shares 46,200 Value ($000) $889 Avg Close $20.66 Range $17.34 - $25.07
Q2 2024
Shares 65,000 Value ($000) $1,334 Avg Close $20.93 Range $18.65 - $24.38
Q1 2024
Shares 65,000 Value ($000) $1,547 Avg Close $22.30 Range $19.58 - $25.34
Q4 2023
Shares 34,500 Value ($000) $746 Avg Close $15.37 Range $11.21 - $21.84
Q3 2023
Shares 34,500 Value ($000) $501 Avg Close $18.92 Range $12.85 - $23.55
Q2 2023
Shares 34,500 Value ($000) $722 Avg Close $20.82 Range $19.27 - $23.14